ARTICLE | Company News
Lexicon, Nuevolution deal
June 16, 2008 7:00 AM UTC
Nuevolution will use its Chemetics fragment-based drug discovery technology to discover potential candidates against undisclosed targets from Lexicon for undisclosed indications. Lexicon used its Geno...